You are here

  • Home
  • Archive
  • Volume 83, Issue Suppl 1
  • Q07 Long-term safety and tolerability of pridopidine in patients with huntington's disease (HD): results of the mermaihd study open-label extension

Citation Tools

Article menu
Download PDFPDF
Clinical therapeutics
Clinical therapeutics
Q07 Long-term safety and tolerability of pridopidine in patients with huntington's disease (HD): results of the mermaihd study open-label extension

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Squitieri F, Landwehrmeyer B, Reilmann R, et al
Q07 Long-term safety and tolerability of pridopidine in patients with huntington's disease (HD): results of the mermaihd study open-label extension
Journal of Neurology, Neurosurgery & Psychiatry 2012;83:A56-A57.